10-Q: Insperity Reports Significant Profit Decline in Q2 2025 Amid Rising Direct Costs

Insperity, Inc. experienced a sharp decline in net income and diluted EPS for the second quarter and first half of 2025, primarily driven by increased health insurance and payroll tax costs, despite modest revenue and worksite employee growth.

Summary

• Revenues for Q2 2025 increased 3% to $1.658 billion, and for the first six months of 2025 increased 3% to $3.521 billion, compared to the same periods in 2024.
• Gross profit for Q2 2025 decreased 14% to $223 million, and for the first six months of 2025 decreased 12% to $533 million.
• Net income for Q2 2025 was a loss of $5 million, a 128% decrease from $18 million income in Q2 2024.
• Net income for the first six months of 2025 decreased 53% to $46 million from $97 million in the first six months of 2024.
• Diluted EPS for Q2 2025 was $(0.14), a 129% decrease from $0.48 in Q2 2024.
• Diluted EPS for the first six months of 2025 decreased 52% to $1.22 from $2.56 in the first six months of 2024.
• Adjusted EBITDA for Q2 2025 decreased 52% to $32 million, and for the first six months of 2025 decreased 36% to $134 million.
• Average worksite employees (WSEEs) paid per month increased 1% for both Q2 2025 and the first six months of 2025.
• Health insurance costs increased $65 per WSEE per month in Q2 2025 and $60 per WSEE per month in YTD 2025, driven by elevated pharmacy trends and large claim activity.
• The company distributed $440 million of client employee retention tax credits in early 2025, which were received on their behalf in Q4 2024.
• As of June 30, 2025, the company had $456 million in cash, cash equivalents, and marketable securities, down from $1.055 billion at December 31, 2024.
• Working capital increased slightly to $160 million at June 30, 2025, from $155 million at December 31, 2024.
• The revolving credit facility has a borrowing capacity of up to $650 million, with $369 million outstanding and $280 million available as of June 30, 2025.

Sentiment

Score: 3

Explanation: The sentiment is negative due to significant year-over-year declines in key profitability metrics (net income, EPS, gross profit, adjusted EBITDA) for both the quarter and year-to-date periods, primarily driven by rising direct costs, particularly health insurance. While revenue and WSEE count saw modest growth, this was overshadowed by the sharp drop in earnings.

Positives

• Revenues increased by 3% for both the second quarter and the first six months of 2025, indicating continued top-line growth.
• Average worksite employees (WSEEs) paid per month increased by 1% year-over-year, reflecting growth in the client base and new client sales.
• Operating expenses decreased by 3% in Q2 2025 and remained relatively flat for the first six months of 2025, demonstrating some cost management.
• General and administrative expenses decreased by 14% in Q2 2025 and 4% in YTD 2025, primarily due to decreased professional services fees, travel, training, and amortization of SaaS implementation costs.
• The company maintained a healthy working capital of $160 million and an available borrowing capacity of $280 million under its credit facility, indicating adequate short-term liquidity.
• The company continues its share repurchase program, with 45,000 shares repurchased in the first six months of 2025, and declared quarterly dividends of $0.60 per share.

Negatives

• Net income for Q2 2025 was a loss of $5 million, a significant decline from $18 million income in Q2 2024.
• Diluted EPS for Q2 2025 was $(0.14), a substantial decrease from $0.48 in Q2 2024.
• Adjusted EBITDA decreased by 52% in Q2 2025 and 36% in the first six months of 2025, indicating a significant reduction in operational profitability.
• Gross profit decreased by 14% in Q2 2025 and 12% in the first six months of 2025, primarily due to higher direct costs.
• Health insurance costs per WSEE per month increased significantly by $65 in Q2 2025 and $60 in YTD 2025, driven by elevated pharmacy trends and large claim activity.
• Changes in estimated claims run-off related to prior periods resulted in an $11 million increase in benefits costs in YTD 2025, contrasting with a $26 million decrease in YTD 2024.
• Cash, cash equivalents, and marketable securities decreased significantly from $1.055 billion at December 31, 2024, to $456 million at June 30, 2025, partly due to the distribution of client employee retention tax credits.

Risks

• Adverse economic conditions could negatively impact business performance.
• Failure to comply with or meet client expectations regarding certain COVID-19 relief programs.
• Bank failures or other events affecting financial institutions could disrupt operations.
• Labor shortages, increasing competition for highly skilled workers, and evolving employee expectations regarding the workplace.
• Impact of inflation and changes in U.S. trade policy.
• Vulnerability to regional economic factors due to geographic market concentration.
• Failure to comply with covenants under the credit facility.
• Impact of a future outbreak of highly infectious or contagious disease.
• Liability for WSEE payroll, payroll taxes, and benefits costs, or other liabilities associated with actions of client companies or WSEEs, including if clients fail to pay.
• Increases in health insurance costs and workers compensation rates and underlying claims trends, health care reform, financial solvency of workers compensation carriers, other insurers or financial institutions, state unemployment tax rates, and liabilities for employee and client actions or payroll-related claims.
• An adverse determination regarding the company's status as the employer of WSEEs for tax and benefit purposes.
• Cancellation of client contracts on short notice, or the inability to renew client contracts or attract new clients.
• The ability to secure competitive replacement contracts for health insurance and workers compensation insurance at expiration of current contracts.
• Regulatory and tax developments and possible adverse application of various federal, state, and local regulations.
• Failure to manage growth of operations and the effectiveness of sales and marketing efforts.
• The impact of the competitive environment and other developments in the human resources services industry, including the PEO industry, on growth and/or profitability.
• An adverse final judgment or settlement of claims against Insperity.
• Disruptions of information technology systems or failure to enhance service and technology offerings to address new regulations or client expectations.
• Liability or damage to reputation relating to disclosure of sensitive or private information as a result of data theft, cyberattacks or security vulnerabilities.
• Failure of third-party providers, such as financial institutions, data centers or cloud service providers.
• Ability to fully realize the anticipated benefits of the strategic partnership and complete the development of the joint solution with Workday, Inc.
• Ability to integrate or realize expected returns on future product offerings, including through acquisitions, strategic partnerships, and investments.

Future Outlook

Management believes that current cash on hand, marketable securities, cash flows from operations, and available credit under the facility will be adequate to meet liquidity requirements for the remainder of 2025. For longer-term liquidity and capital needs, the company intends to rely on these same sources, as well as public and private debt or equity financing. The company is currently evaluating the potential effects of the H.R.1 (One Big Beautiful Bill Act) on its financial position, results of operations, and cash flows, with additional disclosures expected in future periods once the assessment is complete.

Management Comments

• "We currently believe that our cash on hand, marketable securities, cash flows from operations, and availability under the Facility will be adequate to meet our liquidity requirements for the remainder of 2025."
• "We intend to rely on these same sources, as well as public and private debt or equity financing, to meet our longer-term liquidity and capital needs."
• Management believes it has valid defenses in various lawsuits and claims and that the final outcome will not have a material adverse effect on financial position or results of operations.

Industry Context

Insperity operates in the human resources services industry, specifically within the Professional Employer Organization (PEO) sector. The industry is characterized by managing payroll, benefits, and compliance for small and medium-sized businesses. The reported increase in health insurance costs and workers' compensation rates reflects broader inflationary pressures and rising healthcare expenses that are likely impacting the entire PEO industry. Despite these cost pressures, the company's 1% WSEE growth indicates continued demand for PEO services, though profitability is being challenged by the escalating direct costs.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess the company's performance against global benchmarks or direct competitors.

Corporate Governance

Legal Proceedings

• The company is a defendant in various lawsuits and claims arising in the normal course of business. Management believes it has valid defenses and is vigorously defending these cases, asserting that the final outcome will not have a material adverse effect on the financial position or results of operations.

Stakeholder Impact

• Shareholders: Experienced a significant decline in net income and diluted EPS, which could negatively impact stock performance. However, the company continues its share repurchase program and dividend payments.
• Employees (Worksite Employees): Affected by rising health insurance costs and payroll taxes, which are direct costs to the company.
• Clients: Likely facing increased pricing from Insperity due to the company's efforts to offset rising direct costs, potentially impacting their overall HR service expenses.
• Creditors: The company remains in compliance with all financial covenants under its credit agreement, indicating continued financial stability from a debt perspective.

Next Steps

• The company will continue to evaluate the provisions of H.R.1 (One Big Beautiful Bill Act) and its potential effects on financial position, results of operations, and cash flows, with additional disclosures to be provided in future periods.
• Compensation expense for the performance-based stock units granted on July 1, 2025, will be recognized on a straight-line basis over the five-year vesting term, beginning in the third quarter of 2025.

Key Dates

Recommendation

The company experienced a substantial decline in profitability metrics (net income, EPS, adjusted EBITDA, gross profit) for both the quarter and year-to-date periods, primarily due to significant increases in direct costs, particularly health insurance. While revenue and WSEE growth were modest, the sharp deterioration in earnings is a major concern. The company maintains adequate liquidity and continues shareholder returns through dividends and share repurchases. However, the negative trend in profitability and rising cost pressures suggest a 'hold' recommendation, as investors should monitor whether the company can effectively manage these rising costs and restore profitability in future periods before considering a 'buy' position. A 'sell' might be considered by more risk-averse investors given the sharp decline in earnings.

Keywords

Human Resources, PEO, Professional Employer Organization, HR Solutions, Payroll, Employee Benefits, Workers Compensation, SEC Filing, Quarterly Report, Financial Performance, Worksite Employees, NSP